Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies.
about
A variant of green fluorescent protein exclusively deposited to active intracellular inclusion bodies.Self-Assembled Proteins and Peptides as Scaffolds for Tissue Regeneration.Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms.Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells.Functional inclusion bodies produced in the yeast Pichia pastoris.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.Inclusion bodies: not that bad….Recombinant protein materials for bioengineering and nanomedicine.Integrating mechanical and biological control of cell proliferation through bioinspired multieffector materials.Functional protein aggregates: just the tip of the iceberg.Eukaryotic aggresomes: from a model of conformational diseases to an emerging type of immobilized biocatalyzers.A novel bio-functional material based on mammalian cell aggresomes.A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.Protein based therapeutic delivery agents: Contemporary developments and challenges.Modeling amyloids in bacteria.Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release.Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells.Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.Packaging protein drugs as bacterial inclusion bodies for therapeutic applicationsTopographically targeted osteogenesis of mesenchymal stem cells stimulated by inclusion bodies attached to polycaprolactone surfaces.Reassessment of inclusion body-based production as a versatile opportunity for difficult-to-express recombinant proteins.Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl.Biomedical Applications of Bacterial Inclusion BodiesEngineering Protein Based Nanoparticles for Applications in Tissue Engineering
P2860
Q33726748-FF166995-2C02-4543-B455-0989BE38EA21Q35804917-ED115E28-C2C8-4C43-9A33-F39491214781Q36157511-8AC606E8-BF18-4540-BCB8-F29D74DB9206Q36209585-4DF76DFA-B1AF-4176-868B-8EAE55E4E3A5Q37302292-E6D84D25-ABB4-458E-A981-359CC1094B22Q38150365-3887931A-039F-4A9F-BE17-CD21084FFA8AQ38193089-EADB69DA-F097-43DC-A0DC-46A097E173F7Q38298810-00407033-E2F7-4487-A331-56698B149D41Q38393746-49E4488E-5CD0-4CCB-B99D-4D962CD6B3E9Q38586804-F6EE6B47-F20A-460A-9213-45626B3A1598Q38622861-62394429-D585-45E0-B789-DCD735E222CEQ38871635-FE9D366A-ACA2-466D-B065-BC51C2055D4DQ39197445-7DA200B0-3786-4D19-8512-9302F8188C2DQ39273739-C5074C3C-749F-4915-AE65-219DB0068E87Q39494485-A7867A60-4088-4A62-B844-847308138621Q39517242-0DF71AF5-85C1-491F-8E37-0796B08E3376Q39937425-8181A422-3226-4664-AFFF-DD3013C3E4E4Q41545294-6B19ED11-2D6D-4898-8D7E-98005FEE6D3EQ42548781-611C0C2F-B757-4B24-B272-685D3FC7E969Q46852097-9EDAA7ED-2A61-4D39-B584-43126ED78987Q47362457-6F144AD2-B951-4869-A9F4-5E5AB09620FEQ55014158-F407DA56-F152-4E76-A5BE-FF88165C0E6DQ59201792-6FB18399-4C57-410E-8C62-D84D594AF229Q59201793-AA40BCDA-EA67-48C2-8641-8EA1323D6632
P2860
Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Functional inclusion bodies pr ...... s for advanced cell therapies.
@en
Functional inclusion bodies pr ...... s for advanced cell therapies.
@nl
type
label
Functional inclusion bodies pr ...... s for advanced cell therapies.
@en
Functional inclusion bodies pr ...... s for advanced cell therapies.
@nl
prefLabel
Functional inclusion bodies pr ...... s for advanced cell therapies.
@en
Functional inclusion bodies pr ...... s for advanced cell therapies.
@nl
P2093
P2860
P50
P356
P1433
P1476
Functional inclusion bodies pr ...... ls for advanced cell therapies
@en
P2093
Joan F Burgueño
Luis Ruiz-Avila
Ramon Bosser
Ursula Rinas
P2860
P304
P356
10.1002/ADMA.201104330
P407
P50
P577
2012-03-13T00:00:00Z